Although asthma and Chronic Obstructive Pulmonary Disease (COPD) cannot be strictly classified as autoimmune diseases, the involvement of a variety of cells responsible for immune response and the upregulation of TNF-α in these respiratory disorders strongly suggests the benefit of drugs able to inhibit immunocompetent cell proliferation and cytokine production. Here, TNF is linked to chronic obstructive pulmonary disease.